Develops pharmacological agents that stimulate mitochondrial thermogenesis, activating calorie-burning processes previously inhibited by modern living conditions. This approach targets metabolic disorders, including obesity, by providing a drug-based solution for sustained weight loss and improved metabolic health.
Funding
$650K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ARSHFounders
Product
Problem
Obesity and related metabolic disorders are significant health challenges, affecting nearly 50% of Americans. Current treatments primarily focus on diet and exercise, which often fail to produce sustained weight loss for many individuals. A critical mechanism for weight regulation, natural heat production or thermogenesis, is often inhibited by modern, temperature-controlled living conditions.
Solution
Equator Therapeutics is developing a first-in-class drug that stimulates mitochondrial thermogenesis to address metabolic disorders and obesity. The company's approach targets mitochondria, the cellular organelles responsible for burning calories to generate heat. By pharmacologically stimulating thermogenesis, Equator Therapeutics aims to activate calorie-burning processes that are naturally suppressed in contemporary lifestyles. This innovative approach seeks to provide a drug-based solution for sustained weight loss and improved metabolic health by restoring natural heat production.
Target Audience
The primary target audience includes individuals with obesity and related metabolic disorders, as well as healthcare providers seeking novel therapeutic interventions for these conditions.
Features
- Utilizes high-throughput assays to identify thermogenic compounds.
- Employs methods to directly record electrical currents induced by compounds in mitochondria.
- Selects for selective and safe activators of thermogenesis.
- Focuses on pharmacological stimulation of thermogenesis.
- Developing drugs that modulate mitochondrial energy production.